UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:May 26,
Protara Therapeutics (NASDAQ:TARA)
Historical Stock Chart
From Sep 2024 to Oct 2024 Click Here for more Protara Therapeutics Charts.
Protara Therapeutics (NASDAQ:TARA)
Historical Stock Chart
From Oct 2023 to Oct 2024 Click Here for more Protara Therapeutics Charts.

Protara Therapeutics, Inc. News

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 12 September 2024 (4 weeks ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 10 September 2024 (4 weeks ago) • Edgar (US Regulatory)
Protara Therapeutics Announces Completion of First Cohort in Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations
Monday 9 September 2024 (1 month ago) • GlobeNewswire Inc.
Protara Therapeutics Announces Results from THRIVE-1, a Prospective Observational Study Evaluating the Prevalence of Choline Deficiency and Liver Injury in Patients Dependent on Parenteral Support
Monday 9 September 2024 (1 month ago) • GlobeNewswire Inc.
Protara Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Tuesday 3 September 2024 (1 month ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Friday 30 August 2024 (1 month ago) • Edgar (US Regulatory)
Form S-8 - Securities to be offered to employees in employee benefit plans
Tuesday 6 August 2024 (2 months ago) • Edgar (US Regulatory)
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 6 August 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 6 August 2024 (2 months ago) • Edgar (US Regulatory)
Protara Therapeutics Announces Second Quarter 2024 Financial Results and Provides a Business Update
Tuesday 6 August 2024 (2 months ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 18 July 2024 (3 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Thursday 11 July 2024 (3 months ago) • Edgar (US Regulatory)

More Protara Therapeutics, Inc. News Articles